期刊
PHARMACEUTICAL RESEARCH
卷 32, 期 11, 页码 3577-3583出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-015-1729-8
关键词
Antibody drug conjugate; Internalization; Recycling; Trafficking; Linker
This review discusses the molecular mechanism involved in the targeting and delivery of antibody-drug conjugates (ADCs), the new class of biopharmaceuticals mainly designed for targeted cancer therapy. this review goes over major progress in preclinical and clinical studies of ADCs, in the past 5 years. The pharmacokinetics and pharmacodynamics of ADCs involve multiple mechanisms, including internalization of ADCs by target cells, intracellular trafficking, release of conjugated drugs, and payload. These mechanisms actually jointly determine the efficacy of ADCs. Therefore, the optimization of ADCs should take them as necessary rationales.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据